Yimin Cui

7.9k total citations · 2 hit papers
266 papers, 4.5k citations indexed

About

Yimin Cui is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Yimin Cui has authored 266 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Cardiology and Cardiovascular Medicine, 55 papers in Surgery and 39 papers in Molecular Biology. Recurrent topics in Yimin Cui's work include Venous Thromboembolism Diagnosis and Management (23 papers), Antiplatelet Therapy and Cardiovascular Diseases (23 papers) and Atrial Fibrillation Management and Outcomes (20 papers). Yimin Cui is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (23 papers), Antiplatelet Therapy and Cardiovascular Diseases (23 papers) and Atrial Fibrillation Management and Outcomes (20 papers). Yimin Cui collaborates with scholars based in China, United States and Estonia. Yimin Cui's co-authors include Qian Xiang, Ying Zhou, Xia Zhao, Xiaocong Pang, Hanxu Zhang, Yanlun Gu, He Xu, Xiaocong Pang, Zhiwei Qiu and Ran Xie and has published in prestigious journals such as Nature Communications, PLoS ONE and Hepatology.

In The Last Decade

Yimin Cui

253 papers receiving 4.4k citations

Hit Papers

Targeting integrin pathways: mechanisms and advances in t... 2023 2026 2024 2025 2023 2024 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yimin Cui China 31 1.0k 694 539 454 412 266 4.5k
Qian Zhou China 32 874 0.8× 635 0.9× 624 1.2× 443 1.0× 345 0.8× 246 4.4k
Qian Zhou China 32 1.2k 1.1× 784 1.1× 642 1.2× 309 0.7× 351 0.9× 171 3.9k
Pieter Vermeersch Belgium 40 1.2k 1.1× 539 0.8× 693 1.3× 227 0.5× 396 1.0× 173 5.1k
Xiao Huang China 29 744 0.7× 427 0.6× 581 1.1× 300 0.7× 214 0.5× 200 3.4k
Conghui Han China 17 757 0.7× 1.1k 1.5× 373 0.7× 676 1.5× 291 0.7× 76 4.6k
Yanni Wang China 29 1.3k 1.2× 356 0.5× 294 0.5× 320 0.7× 287 0.7× 186 3.7k
Li China 29 1.0k 1.0× 623 0.9× 267 0.5× 333 0.7× 247 0.6× 672 4.0k
Chen‐Li Cheng Taiwan 30 1.1k 1.1× 962 1.4× 317 0.6× 414 0.9× 323 0.8× 204 5.3k
Kálmán Tóth Hungary 37 1.2k 1.1× 1.1k 1.5× 1.1k 2.1× 369 0.8× 348 0.8× 185 4.8k
Dan Liu China 36 1.0k 1.0× 464 0.7× 470 0.9× 845 1.9× 475 1.2× 253 4.4k

Countries citing papers authored by Yimin Cui

Since Specialization
Citations

This map shows the geographic impact of Yimin Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yimin Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yimin Cui more than expected).

Fields of papers citing papers by Yimin Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yimin Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yimin Cui. The network helps show where Yimin Cui may publish in the future.

Co-authorship network of co-authors of Yimin Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Yimin Cui. A scholar is included among the top collaborators of Yimin Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yimin Cui. Yimin Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhang, Junling, Qingqing Xiong, Xin Wang, et al.. (2024). Targeting SLITRK4 Restrains Proliferation and Liver Metastasis in Colorectal Cancer via Regulating PI3K/AKT/NFκB Pathway and Tumor‐Associated Macrophage. Advanced Science. 12(1). e2400367–e2400367. 6 indexed citations
3.
Wang, Zhe, et al.. (2024). C-type lectin-like receptor 2: roles and drug target. Thrombosis Journal. 22(1). 27–27. 5 indexed citations
4.
Li, Shuangshuang, Jinghui Tong, Junchao Huang, et al.. (2023). Short-term antipsychotic treatment response in early-onset, typical-onset, and late-onset first episode schizophrenia. Schizophrenia Research. 257. 58–63. 3 indexed citations
6.
Li, Wenhui, Mingli Gong, Yanlun Gu, et al.. (2023). Risk of venous thromboembolism with janus kinase inhibitors in inflammatory immune diseases: a systematic review and meta-analysis. Frontiers in Pharmacology. 14. 1189389–1189389. 23 indexed citations
7.
Liu, Zhiyan, Longtu Li, Hanxu Zhang, et al.. (2023). Platelet factor 4(PF4) and its multiple roles in diseases. Blood Reviews. 64. 101155–101155. 22 indexed citations
8.
Ji, Xiwei, Xiangrui Meng, Xiao Zhu, Qingfeng He, & Yimin Cui. (2022). Research and development of Chinese anti-COVID-19 drugs. Acta Pharmaceutica Sinica B. 12(12). 4271–4286. 17 indexed citations
9.
Zhang, Hanxu, Shuang Zhou, Zhiyan Liu, et al.. (2022). Ferroptosis of Endothelial Cells in Vascular Diseases. Nutrients. 14(21). 4506–4506. 22 indexed citations
10.
Zhang, Ping, Junchao Huang, Yanfang Zhou, et al.. (2021). Kynurenine metabolism and metabolic syndrome in patients with schizophrenia. Journal of Psychiatric Research. 139. 54–61. 10 indexed citations
11.
Wang, Leilei, Yanfang Zhou, Junchao Huang, et al.. (2021). The mediating effect of brain-derived neurotrophic factor levels on childhood trauma and psychiatric symptoms in patients with first-episode schizophrenia. Australian & New Zealand Journal of Psychiatry. 56(7). 828–835. 7 indexed citations
14.
Zhang, Yuanyuan, Jing Nie, Yan Zhang, et al.. (2020). Degree of Blood Pressure Control and Incident Diabetes Mellitus in Chinese Adults With Hypertension. Journal of the American Heart Association. 9(16). e017015–e017015. 20 indexed citations
15.
Dong, Wen‐Liang, Xiaoyan Nie, Jiaxue Wang, et al.. (2020). Randomised, double-blind, multicentre, phase Ⅰ/Ⅱ dose escalation and expansion trial of GR1501 in patients with plaque psoriasis: study protocol. BMJ Open. 10(11). e039067–e039067. 5 indexed citations
16.
Li, Xin, Lihua Liu, Bing Xu, et al.. (2020). Bioequivalence and pharmacodynamics of a generic dabigatran etexilate capsule in healthy Chinese subjects under fasting and fed conditions. Pharmacology Research & Perspectives. 8(2). e00593–e00593. 7 indexed citations
17.
Yang, Ting, Min Li, Chaoyang Chen, et al.. (2019). Efficacy and safety of sapropterin dihydrochloride in patients with phenylketonuria: A meta‐analysis of randomized controlled trials. British Journal of Clinical Pharmacology. 85(5). 893–899. 17 indexed citations
18.
Pang, Xiaocong, Ying Zhao, Jinhua Wang, et al.. (2019). Competing Endogenous RNA and Coexpression Network Analysis for Identification of Potential Biomarkers and Therapeutics in association with Metastasis Risk and Progression of Prostate Cancer. Oxidative Medicine and Cellular Longevity. 2019. 1–21. 9 indexed citations
19.
Ma, Lingyun, Qian Xiang, Xueying Li, et al.. (2017). Vancomycin-associated acute kidney injury: A cross-sectional study from a single center in China. PLoS ONE. 12(4). e0175688–e0175688. 34 indexed citations
20.
Cui, Yimin, Simone Carradori, Dimitra Hadjipavlou‐Litina, et al.. (1969). Predictive Value of Methods Measuring Platelet Activation for Ischemic Events in Patients Receiving Clopidogrel: A Meta-analysis. Current Pharmaceutical Design. 25. 1–1. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026